GlassScriptPhysician profile
Marvin D Siegel
NPI 1003905712
$882.22
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $613 · 2020: $248 · 2021: $21.94.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $169.94 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $130.05 | 2019-2020 | |
| Amgen INC. | $124.18 | 2019-2021 | |
| Janssen Biotech, INC. | $52.93 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $51.16 | 2019-2020 | |
| Genzyme Corporation | $45.41 | 2019-2020 | |
| Ucb, INC. | $38.32 | 2019 | |
| Lilly USA, LLC | $37.97 | 2019-2020 | |
| Leo Pharma INC. | $36.53 | 2019 | |
| Sun Pharmaceutical Industries INC. | $35.62 | 2019 | |
| Galderma Laboratories, L.P. | $27.86 | 2019 | |
| Melinta Therapeutics, LLC | $24.04 | 2019 | |
| Mayne Pharma Commercial LLC | $21.13 | 2019 | |
| Almirall LLC | $20.41 | 2020 | |
| Aclaris Therapeutics, INC. | $18.30 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $16.40 | 2019 | |
| Janssen Scientific Affairs, LLC | $16.12 | 2019 | |
| Prugen, INC. Pharmaceuticals | $15.85 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marvin Siegel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.